Event-Driven Stocks

Strongbridge Biopharma plc

Healthcare · Pharmaceutical Preparations · L2 · SEC filings ↗ · Compare ⊕

Signs● 2 good● 4 warning● 1 severedetails ↓

Financials

SEC XBRL · annual
 FY20FY19FY18FY17FY16
Revenue$30.7M$21.7M$18.0M$7.0M—
Operating income−$43.2M−$67.1M−$81.9M−$73.7M−$50.7M
Net income−$12.7M−$18.4M$31.9M−$113.5M−$48.6M
Total assets$121.1M$117.6M$170.3M$103.9M$137.5M
Total liabilities$55.5M$45.4M$57.3M$115.8M$70.6M
Equity$65.6M$72.2M$113.0M−$11.9M$67.0M
EPS (diluted)$-0.24$-1.10$0.31$-3.11$-2.27
Shares out.54.2M54.2M45.5M40.1M35.3M

Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.

Key ratios

from filings · FY2020
Operating margin
−140.5%
Net margin
−41.3%
Return on equity
−19.4%
Return on assets
−10.5%
Return on capital (ROCE)
−43.2%
Liabilities / assets
45.8%
Debt / equity
0.85×
Book value / share
$1.21
Revenue growth (YoY)
41.5%
Net income growth (YoY)
—

Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.

Financial health

forensic scores · FY2020
Altman Z″ (distress)
-5.52distress
Accruals / assets
21.0%high accruals
Piotroski F-Score
4/9mixed

Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.

Quality score

EDS Score
42
/ 100
Profitability 0Growth 100Catalyst 33Earnings quality 0Financial strength 75

Our own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.

Signs

● 1 severe● 4 warning● 2 good
  • Altman Z″ in the distress zone
  • Operating losses (negative operating margin)
  • Reported a net loss
  • Negative operating cash flow
  • High accruals — earnings-quality risk
  • Revenue is growing year-over-year
  • Conservative leverage (liabilities < 50% of assets)

Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.

Material events

SEC Form 8-K · most recent

Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.

Recent SEC filings

All filings ↗

Event-driven situations (1)